T cell regulation in adult transplantation tolerance

Journal of Immunology

Volumn 157, Issue 2, 1996, Pages 529-533

  Davies, Joanna D ^a,b   Martin, Gilly ^a,c   Phillips, Jenny ^a   Marshall, Sara E ^a,d   Cobbold, Stephen P ^a,e   Waldmann, Herman ^a,e  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Cantab Pharmaceuticals Ltd   (United Kingdom)

^d CHURCHILL HOSPITAL   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 4; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; OKT 4; OKT 8;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN GRAFT; SPLEEN CELL; SUPPRESSOR CELL; TRANSPLANTATION;

ADOPTIVE TRANSFER; AGING; ANIMALS; IMMUNE TOLERANCE; INTERLEUKIN-4; LYMPHOCYTE COUNT; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; SKIN TRANSPLANTATION; T-LYMPHOCYTES, REGULATORY;

EID: 0030006103     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Kimura, H., and D. B. Wilson. 1984. Anti-idiotypic cytotoxic T cells in rats with graft-versus-host disease. Nature 308:463.
2. + T lymphocytes. J. Immunol. 142:748.
3. Miller, A., O. Lider, and H. L. Weiner. 1991. Antigen-driven bystander suppression after oral administration of antigens. J. Exp. Med. 174:791.
4. Qin, S., S. P. Cobbold, H. Pope, J. Elliott, D. Kioussis, J. Davies, and H. Waldmann. 1993. 'Infectious' tolerance. Science 259:974.
5. Miller, A., O. Lider, A. B. Robers, M. B. Sporn, and H. W. Weiner. 1992. Suppressor T cells generated by oral tolerisation to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc. Natl. Acad. Sci. USA 89:421.
6. Chen, Y., V. K. Kuchroo, J. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237.
7. Bellgrau, D., and D. B. Wilson. 1979. Immunological studies of T-cell receptors. II. Limited polymorphism of idiotypic determinants on T cell receptors specific for major histocompatibility complex antigens. J. Exp. Med. 149:234.
8. Holan, V., and N. A. Mitchison. 1983. Haplotype-specific suppressor T cells mediating linked suppression of immune responses elicited by third party H-2 alloantigens. Eur J. Immunol. 13:652.
9. Lancaster, F., Y. L. Chui, and J. R. Batchelor. 1985. Anti-idiotypic T cells suppress rejection of renal allografts in rats. Nature 315:336.
10. Lombardi, G., S. Sidhu, R. Batchelor, and R. Lechler. 1994. Anergic T cells suppress cells in vitro. Science 264:1587.
11. Qin, S., M. Wise, S. P. Cobbold, L. Leong, Y.-C. Kong, J. R. Parnes, and H. Waldmann. 1990. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur. J. Immunol. 20:2737.
12. Mosmann, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145.
13. Swain, S. L., L. M. Bradley, M. Croft, S. Tonkonogy, G. Atkins, A. D. Weinberg, D. D. Duncan, S. M. Hedrick, R. W. Dutton, and G. Huston. 1991. Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol. Rev. 123:115.
14. + T cells and their roles in the induction and prevention of autoimmunity. Immunol. Rev. 123:37.
15. + T cell subset that inhibits this autoimmune potential. J. Exp. Med. 177:627.
16. + T cells. J. Exp. Med. 178:237.
17. Dallman, M. J., C. P. Larsen, and P. J. Morris. 1991. Cytokine gene transcription in vascularised organ grafts: analysis using semi-quantitative polymerase chain reaction. J. Exp. Med. 174:493.
18. Killar, L., G. MacDonald, J. West, A. Woods, and K. Bottomly. Cloned, Ia-restricted T cells that do not produce interleukin 4 (IL 4)/B cell stimulatory factor 1 (BSF-1) fail to help antigen-specific B cells. 1987. J. Immunol. 138:1674.
19. Boom, W. H., D. Liano, and A. K. Abbas. 1988. Heterogeneity of helper/inducer T lymphocytes. II. Effects of interleukin 4- and interleukin 2-promoting T cell clones on resting B lymphocytes. J. Exp. Med. 167:1350.
20. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 directs the development of Th2-like helper effectors. J. Immunol. 145:3796.
21. Sadick, M. D., F. P. Heinzel, B. J. Holaday, R. T. Pu, R. S. Dawkins, and R. M. Locksley. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody: evidence for a T cell-dependent interferon-γ-independent mechanism. J. Exp. Med. 171:115.
22. Florentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444.
23. Minty, A., P. Chalon, J.-M. Derocq, X. Dumont, J.-C. Guillemot, M. Kaghad, C. Labit, P. Leplatois, P. Liauzun, B. Miloux, C. Minty, P. Casellas, G. Loison, J. Lupker, D. Shire, P. Ferrara, and D. Caput. 1993. Interleukin-13 is a new lymphokine regulating inflammatory and immune responses. Nature 362:248.
24. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J. Exp. Med. 179:589.
25. Cobbold, S. P., A. Jayasuria, A. Nash, T. D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312:548.
26. Qin, S., S. Cobbold, H. Tighe, R. Benjamin, and H. Waldmann. 1987. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction. Eur. J. Immunol. 17:1159.
27. Cobbold, S., and S. Metcalfe. 1994. Monoclonal antibodies that define canine homologues of human CD antigens: summary of the first International Canine Leukocyte Antigen Workshop (CLAW). Tissue Antigens 43:13.
28. Ohara, J., and W. E. Paul. 1985. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 315:333.
29. Billingham, R. E., L. Brent, and P. B. Medawar. 1953. 'Actively acquired tolerance' of foreign cells. Nature 172:603.
30. Peto, R., M. C. Pike, P. Armitage, N. E. Breslow, D. R. Cox, S. V. Howard, N. Mantel, K. McPherson, J. Peto, and P. G. Smith. 1977. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer 35:1.
31. + T cells in the presence of a nondepleting monoclonal antibody to CD5 induces a Th2-type response in vitro. J. Exp. Med. 182:5.
32. Brocke, S., K. Gijbels, M. Allegretta, I. Ferber, C. Piercy, T. Blankenstein, R. Martin, U. Utz, N. Karin, D. Mitchell, T. Veromaa, A. Waisman, A. Gaur, P. Conlon, N. Ling, P. J. Fairchild, D. C. Wraith, A. O'Garra, C. G. Fathman, and L. Steinman. 1996. Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379:343.
33. Rapoport, M. J., A. Jaramillo, D. Zipris, A. H. Lazarus, D. V. Serreze, E. H. Leiter, P. Cyopick, J. S. Danska, and T. L. Delovitch. 1993. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in non-obese diabetic mice. J. Exp. Med. 178:87.
34. Howard, M., J. Farrar, M. Hilfiker, B. Johnson, K. Takatsu, T. Hamaoka, and W. E. Paul. 1982. Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J. Exp. Med. 155:914.
35. Brown, M. A., J. H. Pierce, C. J. Watson, J. Falco, J. N. Ihle, and W. E. Paul. 1987. B cell stimulating factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell 50:809.
36. Brunner, T., C. H. Heussner, and C. A. Dahinden. 1993. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J. Exp. Med. 177:605.
37. Cobbold, S. P., E. Adams, S. E. Marshall, J. D. Davies, and H. Waldmann. 1996. Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol. Rev. 149:5.
38. + T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J. Exp. Med. 181:1081.
39. + T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J. Exp. Med. 182:1579.
40. + T cells. J. Exp. Med. 182:1591.
41. Sayegh, M. H., E. Akalin, W. W. Hancock, M. E. Russell, C. B. Carpenter, P. S. Linsley, and L. A. Turka. 1995. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 181:1869.